Mon-Parin Injection

Heparin, an anticoagulant, prevents blood clot formation by enhancing the activity of antithrombin III. By inhibiting clotting factors, particularly thrombin, it significantly reduces the risk of thromboembolic events. Heparin is commonly used in various medical settings, including surgeries and the treatment of conditions such as deep vein thrombosis and pulmonary embolism.

• This medicine will be provided by your doctor or nurse; please avoid self-administration.
• Do not take it on your own; wait for guidance from your doctor or nurse.
• Trust your healthcare professional to administer the medicine; do not attempt self-administration.

• Heparin increases the risk of bleeding, and this risk is dosedependent Higher doses, such as 25,000 IU, are associated with an increased bleeding risk Careful monitoring of the patient''s coagulation status, including partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT), is crucial to adjust the dosage and minimize the risk of bleeding
• Subcutaneous administration of heparin, especially at higher doses, can lead to bleeding at the injection site Rotating injection sites and avoiding areas with visible vessels or recent bruising can help minimize this risk

• Prevents and treats blood clots.
• Used in conditions like deep vein thrombosis and pulmonary embolism.
• Maintains blood flow.

• Common side effects include bleeding or bruising
• Allergic reactions may occur